Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation-Reference-Cited by-同舟云学术

Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation

Published:2023-10 Issue: Volume:96 Page:104788
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Garner-Spitzer Erika^ORCID,Wagner Angelika,Gudipati Venugopal,Schoetta Anna-Margarita,Orola-Taus Maria,Kundi Michael,Kunert Renate,Mayrhofer Patrick,Huppa Johannes B.,Stockinger Hannes^ORCID,Carsetti Rita,Gattinger Pia,Valenta Rudolf,Kratzer Bernhard^ORCID,Sehgal Al Nasar Ahmed,Pickl Winfried F.,Reinisch Walter,Novacek Gottfried,Wiedermann Ursula^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference51 articles.

1. SARS-CoV-2-mRNA booster vaccination reverses non-responsiveness and early antibody waning in immunocompromised patients - a phase four study comparing immune responses in patients with solid cancers, multiple myeloma and inflammatory bowel disease;Wagner;Front Immunol,2022

2. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies;Ng;Lancet,2017

3. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Alatab;Lancet Gastroenterol,2020

4. Pathophysiology of inflammatory bowel diseases;Chang;N Engl J Med,2020

5. Targeting immune cell circuits and trafficking in inflammatory bowel disease;Neurath;Nat Immunol,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment;Vaccine;2024-11

2. T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study;eBioMedicine;2024-10

3. Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort Study;2024-09-12

4. Anti‐TNF therapy impairs both short‐ and long‐term IgG responses after repeated vaccination;Allergy;2024-07-25

5. Therapeutic effects of epigallocatechin-3-gallate for inflammatory bowel disease: A preclinical meta-analysis;Phytomedicine;2024-06